Boston Scientific launches a U.S. clinical trial of its Lotus transcatheter aortic valve implant in high-and extreme-risk patients.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xfMsm6
Cap comentari:
Publica un comentari a l'entrada